Sturm, Ruger & Company, Inc. — FY2023 Form 10-K
Reporting period: Fiscal year ended December 31, 2023. The filing is an annual report, not a standalone fourth-quarter filing; Q4 comparisons are included below. Unless noted, dollar amounts are in millions.
Business context
Ruger designs, manufactures, and sells firearms, primarily in the United States through independent wholesale distributors. Firearms generated nearly all sales; castings were less than 1%. Export sales were about 6% of consolidated sales. Three distributors accounted for 58% of firearms sales in 2023.
Financial performance and liquidity
| Metric | FY2023 | FY2022 | Change |
|---|---|---|---|
| Net sales | $543.8 | $595.8 | Down 8.7% |
| Gross profit / margin | $133.6 / 24.6% | $180.1 / 30.2% | Down $46.5; margin down 5.6 percentage points |
| Operating income / margin | $52.1 / 9.6% | $103.5 / 17.3% | Down $51.4 |
| Net income | $48.2 | $88.3 | Down 45.4% |
| Diluted EPS | $2.71 | $4.96 | Down 45.4% |
| EBITDA and EBITDA margin (non-GAAP) | $75.9 / 14.0% | $131.8 / 22.1% | Down $55.8; margin down 8.1 points |
Firearms sales declined 8.9%, while unit shipments fell 17%. Average firearm selling price rose to $395 from $362. New products contributed $121.7 million, or 23% of firearms sales, versus $78.4 million, or 14%, in 2022. Management attributed lower gross profit to weaker sales, inflationary costs, reduced production and fixed-cost absorption, lower-margin product mix, and higher promotions; pricing partly offset these pressures. Operating expenses rose 6.4% to $81.5 million.
Cash flow and balance sheet: Operating cash flow was $33.9 million, down from $77.2 million. Capital expenditures were $15.8 million; operating cash flow less capital expenditures was approximately $18.1 million. Cash and equivalents were $15.2 million and short-term investments $102.5 million at year-end. Working capital was $208.2 million after the $64.3 million LIFO reserve; the reported current ratio was 4.3 to 1. The $40 million revolving credit line was undrawn. No outstanding borrowings are reported on the balance sheet.
Cash declined from $65.2 million to $15.2 million during the year. Financing included $110.8 million of dividends paid, including the $88.3 million special dividend declared in 2022 and paid in January 2023, and $11.8 million of share repurchases. The company ended the year with $74.7 million of repurchase authorization remaining.
Fourth-quarter results
Q4 2023 sales were $130.6 million, down 12.5% from $149.2 million in Q4 2022. Gross profit was $32.3 million versus $39.6 million, and gross margin was 24.7% versus 26.5%. Net income was $10.2 million, compared with $19.0 million; diluted EPS was $0.58 versus $1.06.
Demand, outlook, risks, and contingencies
- Estimated distributor-to-retailer sell-through fell 7% in 2023, compared with a 4% decline in adjusted NICS checks. Management said competitors’ promotions, discounts, rebates, and extended payment terms may have contributed to Ruger’s greater decline. These sell-through figures are company estimates and exclude retailer inventory changes.
- Production fell 19%; year-end backlog declined to $229.0 million from $314.4 million. Company finished-goods inventory increased by 30,700 units, while distributor inventory decreased by 39,100 units.
- No specific 2024 sales or earnings guidance is provided. Management estimated 2024 capital expenditures of approximately $15 million and an effective tax rate of approximately 21%. The board authorized a dividend of $0.23 per share in February 2024. Management stated available cash, operating cash flow, and access to capital should fund anticipated needs.
- Key risks include uncertain firearm demand and regulation, intense competition, dependence on a limited number of distributors and major customers, raw-material and labor cost or supply pressures, manufacturing-site disruptions, product quality and recalls, cybersecurity, and litigation. The company self-insures significant portions of certain risks and carries substantial deductibles.
- At year-end, Ruger was a defendant in nine lawsuits and aware of other claims, including product-liability, municipal, negligence, and unfair-trade-practices matters. The First Circuit reversed dismissal of Mexico’s lawsuit in January 2024 and remanded it for further proceedings. Management said litigation was unlikely to materially affect financial position, but could materially affect results or cash flows in a particular period. The recorded product-liability reserve was $0.7 million.
- The auditor issued unqualified opinions on the financial statements and internal control over financial reporting; management also concluded controls were effective.
Important facts for investors to verify
- Whether sell-through, backlog, and distributor inventories indicate stabilizing end-market demand, and how competitor promotions affect pricing and margins.
- Whether inventory growth, including the LIFO reserve and excess/obsolescence reserve, creates future cash-flow or write-down risk.
- The status and potential financial implications of the Mexico appeal and other litigation, including the limits and exclusions in product-liability insurance.
- How cash generation supports planned capital expenditures, variable dividends, and repurchases as earnings have declined.
- Customer and distributor concentration: the three largest distributors represented 58% of firearms sales, and the filing identifies distributor financial health as a risk.